The preoperative prediction of microvascular invasion in hepatocellular carcinoma using rediomics features of multi-modal dual energy CT image and machine learning technologies

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300075185

Enrollment

Unknown

Registered

2023-08-29

Start date

2023-09-01

Completion date

Unknown

Last updated

2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Gold Standard:Pathological examination

Index test:Dual-energy CT multi-modal images, including Monochromatic image, Iodine/water image, Water/iodine image, and Effective atomic number image.

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. All patients are primary HCC; 2. The patient underwent dual energy CT enhanced scanning within one month before surgery; 3. The patient's clinical and pathological data is complete; 4. The patient did not undergo other HCC related treatments (such as radiotherapy, chemotherapy, radiofrequency ablation, etc.) before surgery, and CT imaging diagnosis did not reveal any visible portal vein branch tumor thrombus.

Exclusion criteria

Exclusion criteria: 1. HCC recurrence or metastasis; 2. Poor image quality (such as metal artifacts or large motion artifacts, etc.); 3. The patient refuses to sign the informed consent form.

Design outcomes

Primary

Measure	Time frame
Accuracy, Acc;Sensitivity, Sens;Specificity, Spec;Area under the ROC curve, AUC;	—

Countries

China

Contacts

Public ContactJiale Zeng

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

jiale_zeng@outlook.com+86 156 2786 5404

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026